Corvus Pharmaceuticals (CRVS) Operating Leases (2019 - 2026)
Corvus Pharmaceuticals (CRVS) posted quarterly Operating Leases of $406000.0 for Q1 2026, down 51.32% year-over-year from $834000.0 in Q1 2025, and down 23.97% quarter-over-quarter from $534000.0 in Q4 2025.
Corvus Pharmaceuticals (CRVS) Operating Leases (2019 - 2026) Analysis & Trends
Corvus Pharmaceuticals' Operating Leases history runs 8 years deep, the most recent figure standing at $406000.0 for Q1 2026.
- In Q1 2026, Operating Leases fell 51.32% year-over-year to $406000.0; the TTM figure through Mar 2026 stood at $406000.0 (down 51.32% YoY), while the FY2025 annual figure was $534000.0, down 43.01% from the prior year.
- Operating Leases for Q1 2026 stood at $406000.0, down from $534000.0 in the prior quarter.
- The five-year high for Operating Leases was $2.3 million in Q1 2022, with the low at $354000.0 in Q3 2023.
- The 5-year median for Operating Leases is $834000.0 (2025), against an average of $999823.5.
- The sharpest annual moves came in 2022 and 2023: Operating Leases surged 216.8% in 2022, then sank 79.04% in 2023.
- Corvus Pharmaceuticals' Operating Leases stood at $1.4 million in 2022, then increased by 0.07% to $1.4 million in 2023, then tumbled by 31.8% to $937000.0 in 2024, then slumped by 43.01% to $534000.0 in 2025, then retreated by 23.97% to $406000.0 in 2026.
- Business Quant data shows CRVS's Operating Leases at $406000.0 in Q1 2026, $534000.0 in Q4 2025, and $632000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Corvus Pharmaceuticals | 1.25 Bn | 1.04 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 274,000.00 |
| Mar 31, 2026 | 406,000.00 |
| Dec 31, 2025 | 534,000.00 |
| Sep 30, 2025 | 632,000.00 |
| Jun 30, 2025 | 728,000.00 |
| Mar 31, 2025 | 834,000.00 |
| Dec 31, 2024 | 937,000.00 |
| Sep 30, 2024 | 354,000.00 |
| Jun 30, 2024 | 700,000.00 |
| Mar 31, 2024 | 1.04 Mn |
| Dec 31, 2023 | 1.37 Mn |
| Sep 30, 2023 | 354,000.00 |
| Jun 30, 2023 | 700,000.00 |
| Mar 31, 2023 | 1.04 Mn |
| Dec 31, 2022 | 1.37 Mn |
| Sep 30, 2022 | 1.69 Mn |
| Jun 30, 2022 | 2.00 Mn |
| Mar 31, 2022 | 2.30 Mn |
| Dec 31, 2021 | 2.60 Mn |
| Sep 30, 2021 | 2.87 Mn |